A review posted in JAMA Network Open emphasizes the discrepancy concerning what it expenses to supply copyright and also the retail rates individuals confront. Despite the low production costs, Novo Nordisk has not publicly disclosed precise figures for copyright or its other item, Wegovy.This led Novo Nordisk to conduct more investigate into bigge